| Financial Year |
March 31 2023 |
| Monetary Funds |
24,824,017,859.15 |
| Held-for-trading Financial Assets |
8,041,192,980.91 |
| Notes Receivable |
209,110,850.00 |
| Accounts Receivable |
5,350,501.05 |
| Advances to Suppliers |
48,044,651.35 |
| Other Receivables |
136,048,124.73 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
16,454,652,371.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
219,285,217.88 |
| Total Current Assets |
49,945,049,606.07 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,226,180,149.37 |
| Investment Properties |
-- |
| Fixed Assetes |
5,674,018,114.69 |
| Under-construction Projects |
828,900,624.87 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,702,948,969.88 |
| R&D expenses |
-- |
| Goodwill |
276,001,989.95 |
| Long-Term Deferred and Prepaid Expenses |
11,071,967.28 |
| Deferred Income Tax Assets |
1,348,274,494.09 |
| Other Non-Current Assets |
184,373,187.98 |
| Sub-Total of Non-Current Assets |
17,129,157,582.89 |
| Total Assets |
67,074,207,188.96 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,309,101,797.96 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
345,964,629.47 |
| Taxes Payable |
2,573,681,518.69 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,744,600,398.04 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
20,450,999.29 |
| Other Current Liabilities |
242,261,219.93 |
| Sub-Total of Current Liabilities |
13,210,943,770.20 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
196,382,434.53 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
225,071,178.23 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
515,131,830.36 |
| Total Liabilities |
13,726,075,600.56 |
| Paid-In Capital(Or Share Stock) |
1,506,988,000.00 |
| Capital Surplus |
935,254,256.10 |
| Surplus Reserve |
753,494,000.00 |
| LESS:Treasury Stock |
56,278,680.79 |
| Undistributed Profits |
50,130,159,280.25 |
| Minority Stockholder's Interest |
74,979,860.11 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
53,273,151,728.29 |
| Owner's Equity（Stockholder's Equity） |
53,348,131,588.40 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
67,074,207,188.96 |
